Vaccines: Following the great success of the 4th International Conference on Vaccines & Vaccination, September 24-26, 2014 Valencia, Spain, OMICS Group International is organising the Asia Pacific Global Summit and Expo on Vaccines & Vaccination to be held in Brisbane, Queensland, Australia from July 27-29, 2015. This will be the latest in the OMICS group annual vaccine meeting series with 500 Plus Attendees, to provide a forum where key vaccine stakeholders including academic researchers, public health clinicians, veterinarians, vaccine policy makers, and manufacturers can exchange ideas and collaborate. There will be opportunities for those chosen to present at the meeting to publish a manuscript based on their presentation in the Journal of Vaccines & Vaccination or its sister publication, Immunome Research.
Visitors of the VACCINE ASIA PACIFIC-2015 are industry leaders and professionals of the Medical, Research, Vaccine Business and Vaccine Value Chain community with the following profession areas: Innovators, Disruptors, and Influencers.
This Global vaccine congress, will be held in Australia. Queensland is the centre of a fast growing Australian biotechnology sector, and is also the doorway to the world famous Great Barrier Reef, allowing international delegates to combine business and pleasure. The vaccine market is growing rapidly, with many new challenges including the need for vaccines to counter new emerging threats such as Ebola, Chikungunya and new pandemic influenza strains as well as to counter old enemies including HIV, TB and malaria. Attend Vaccines Asia Pacific-2015 and learn the latest vaccine research from Australia and around the world, in the vibrant city of Brisbane, the capital of Queensland.
Experts outlook on our previous conferences
- Mahesh Mohan, Tulane University Health Science Center, USA
I enjoyed attending the vaccines business meeting and also had the opportunity to meet other researchers and learn about their research for future collaborations. The talks were informative and I had the opportunity to learn new information. Overall, I enjoyed the conference."
- Martin D'Souza, Mercer University, USA
Many thanks as well for organizing this very focused meetings on vaccines
- De-Chu Christopher, International Vaccine Institute, Korea
Many thanks for organizing this great forum for brain storms to occur nonstop
- Donald E. Greydanus, Western Michigan University School of Medicine, USA
Thank you and I enjoyed the vaccines conference as well as the chance to meet with Dr. Gedela Babu to discuss various issues. I wish you continued success with your conferences!
- Hyunah Lee, Sungkyunkwan University School of Medicine, Korea
It was my great pleasure attending and presenting my paper at the Vaccines-2012. I am sure that the conference was successful. And your hospitality left me with deep impression.
For more...
Vaccines research in Asia Pacific:
Transparency Market Research has released a new report on the global foot and mouth disease (FMD) Vaccines market, which forecasts the growth of the overall FMD Vaccines market at a CAGR of 8.8% during the period from 2014 to 2020. The FMD Vaccines market was valued at US$0.51 billion in 2013. Due to the increasing frequency of FMD outbreaks, the report projects that the market will reach a worth of US$0.95 billion by the end of 2020. The report is titled ‘Foot and Mouth Disease Vaccines Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020’.
Depending upon the type of Vaccines, the report segments the global Vaccines market into conventional Vaccines and emergency Vaccines. The conventional Vaccines have been further categorized into aluminum hydroxide or Saponin based Vaccines, and oil-based Vaccines. In 2013, oil-based FMD Vaccines dominated the global FMD Vaccines market with a market share of 63%, owing to its high efficiency and longer effect in treating the disease.
Vaccines for infectious diseases
The World Health Report From 2000:
Global infectious diseases -
According to the size of their impact estimated
1. > 70 millions
Acute respiratory infections (96.7), Diarrhoeal diseases (72.1), HIV/AIDS (89.8)
2. 20-69 millions
Malaria (45.0), Tuberculosis (33.3), Measles (29.8)
3. 10-19 millions
Sexually-transmitted infections (19.7), Pertussis (10.9), Tetanus (12.0)
4. < 10 millions
Lymphatic filariasis and onchocerciasis (6.0), Meningitis (9.8), GI nematode infestations (2.7), Hepatitis (2.8), Leishmaniasis (2), Schistosomiasis (1.9), Trachoma (1.2) and other diseases.
Vaccines for non-Infectious diseases
Non-infectious diseases: These are the Vaccines for diseases which id not caused by the infection
Alzheimer's disease amyloid protein vaccine
Breast cancer vaccine
Ovarian cancer vaccine
Prostate cancer vaccine
Talimogene Laherparepvec (T-VEC), - Herpes virus engineered to produce immune-boosting molecule
For more informative sessions:
Follow
"Vaccines Aisa Pacific-2015 Organizing Committee" congratulates our previous conference best poster award winners and Young Researcher Award winners.
4th International Conference on Vaccines & Vaccination, September 24-26, 2014 Valencia, Spain
- Rong Xu, Cardiff University, UK
Title: IL-34 suppresses Candida albicans induced TNF-α production by M1 macrophages through down-regulation of Dectin-1 and TLR2 expression
- Daisy Vanrompay, Ghent University, Belgium
Title: Protection of chickens against Chlamydia psittaci challenge by mucosal immunization with the major outer membrane protein
- Silvia Vendetti, Istituto Superiore di Sanita, Italy
Title: Retinoic acid promotes long lasting mucosal and systemic immune responses after mucosal priming and systemic boosting in mice
Vaccines Market From $33,140.6 million in 2014, at a CAGR of 11.8%, WHO Expected vaccine technology market is expected to reach $57,885.4 million by 2019. Major factors driving magnification of vaccine technology market include elevating prevalence of diseases, incrementing regime initiatives for expanding immunization across the globe, incrementing company investments in vaccine development, and elevating initiatives by non-regime organizations for vaccinations. However, low accessibility to vaccines in remote areas and stringent regulatory procedures are expected to restrain the magnification of market. Emerging economies such as India and China present an array of opportunities for this market. North America dominates the market, with the U.S. accounting for a major market share. However, Asia is poised to grow at the highest CAGR during the forecast period owing to the governmental initiatives, elevating focus of major players on the Indian vaccine technology market, and incrementing immunization initiatives by organizations such as World Health Organization and GAVI in these regions.
The 4th International Conference on Vaccines & Vaccination, hosted by the OMICS International. It was held inSeptember 24-26, 2014 Valencia, Spain. Generous response and active participation was received from the Editorial Board Members of OMICS International Journals as well as from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2014 from OMICS International. Also, the conference was carried out through various sessions, in which the discussions were held on the following scientific tracks:
• Vaccines and the Basic Immune System
• New Approaches for B and T Cells
• Cellular and Molecular-Based Vaccines
• Vaccines Against Infectious Diseases
• Manufacturing, Production and Development of Vaccines
• Regulatory and Ethical Issues of Vaccines and Public Acceptance
• Current Issues on Clinical Evaluation and Field Trials of Vaccines
• Modern Technologies in Vaccine Discovery and Development
• Age-Specific Immune Response to Vaccination
• Novel Delivery technologies in Vaccines and many more...
The response to 4th International Conference on Vaccines & Vaccination was huge and was attended by about 550 attendees representing 55 countries from different corners of the world. The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the keynote forum. The list included
- Jeffrey B Ulmer, Novartis Vaccines USA
- Ray Spier, Former President, International Society for Vaccines, UK
- Michael G Hanna, CEO, Vaccinogen, Inc., USA and many more...
All the above mentioned Honorable Guests and keynote speakers gave their energetic and fruitful contributions at Vaccines-2014.
All accepted abstracts have been indexed in OMICS International -Journal of Vaccines & Vaccination as a special issue. The theme of this Conference was on “Prospects and Development of Prophylactic & Therapeutic Vaccines”. Based on this, speaker’s discussions included many recommendations.
" Vaccines-2014 Conference Proceedings "
Sponsors and exhibitors
Sanofi Pasteur SA
U.S. Headquarters, Discovery Drive, Swiftwater, PA 18370
Vaccinogen Inc.,
5300 West view Dr # 406, Frederick, MD 21703, United States
Cellular Technology Limited (CTL)
North & South America
CTL Headquarters, 20521 Chagrin Blvd., Shaker Heights, OH 44122-5350 USA,
Gen Phar
600 Seacoast Pkwy # 100, Mt Pleasant, SC 29464, USA
The 3rd International Conference on Vaccines & Vaccination, hosted by the OMICS International. It was held during July 29-31, 2013 at Embassy Suites Las Vegas, USA. Generous response and active participation was received from the Editorial Board Members of OMICS International Journals as well as from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2013 from OMICS International.
The conference was carried out through various sessions, in which the discussions were held on the following scientific tracks
- Innate and Adaptive Immune Responses to Vaccination
- Vaccinations Focusing on Induction of B or T cell Responses
- Novel Approaches in Design of Cellular and Molecular-Based Vaccines
- Vaccines Against Infectious Diseases and Cancers
- Manufacturing, Production, and Development of Vaccines
- Regulatory and Ethical Issues of Vaccines and Public Acceptance
- Translational, Clinical Evaluation and Field Trials of Vaccines
- Modern Technologies in Vaccine Discovery and Development
- Age-specific Immune Response to Vaccination
" Vaccines-2013 Conference Proceedings "
The response to 3rd International Conference on Vaccines & Vaccination was huge and was attended by about 200 delegates representing 25 countries from different corners of the world.
The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the keynote forum. The list included
- Peter L. Nara, Biological Mimetics, Inc.,USA
- Nikolai Petrovsky, Flinders University, Australia
- De-chu Christopher Tang, International Vaccine Institute, Korea
- Brenda S Atchison, The Alliance for Multispecialty Research, LLC, USA
- John Martin, Institute of Progressive Medicine, USA
- Ara Hovanessian, CNRS University Paris Descartes, France
- Malcolm Thomas, Arbovax, Inc., USA
- Haval Shirwan, University of Louisville, USA and many...
All the above mentioned Honorable Guests and keynote speakers gave their energetic and fruitful contributions at Vaccines-2013.
All accepted abstracts have been indexed in OMICS International Journal of Vaccines & Vaccination as a special issue. The theme of this Conference was on “Recent Innovations and Benchmark Practices in Vaccines & Vaccination". Based on this, speaker's discussions included many recommendations.
We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Vaccines-2013, and with their unique feedback, OMICS International would like to announce the "4th International Conference on Vaccines & Vaccination" to be held at Valencia, Spain on the September 24-26, 2014.
The 2nd International Conference on Vaccines & Vaccination, hosted by the OMICS International. It was held in August 20-22, 2012 in Hilton Chicago/Northbook, USA. Generous response and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2012 from OMICS International.
The conference was carried out through various sessions, in which the discussions were held on the following scientific tracks:
· Vaccines and the Basic Immune System
· New Approaches for B and T Cells
· Cellular and Molecular-Based Vaccines
· Vaccines Against Infectious Diseases
· Manufacturing, Production and Development of Vaccines
· Regulatory and Ethical Issues of Vaccines and Public Acceptance
· Current Issues on Clinical Evaluation and Field Trials of Vaccines
· Modern Technologies in Vaccine Discovery and Development
· Age-Specific Immune Response to Vaccination
The response to 2nd International Conference on Vaccines & Vaccination was huge and was attended by about 200 delegates representing 25 countries from different corners of the world.
The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the keynote forum. The list included
- De-Chu Christopher Vaxin Inc., USA
- John Dong GenPhar, USA
- Donald E. Greydanus Western Michigan University School of Medicine, USA
- Eli Young OpSaniTx, USA
- Takashi Kei Kishimoto Selecta Biosciences, USA
- Daniel H Zimmerman CEL-SCI Corporation, USA
- Gerardo KaplanFood and Drug Administration, USA
- Kei Amemiya U.S. Army Medical Research Institute of Infectious Diseases, USA
- Haval Shirwan University of Louisville, USA
All the above mentioned Honorable Guests and keynote speakers gave their energetic and fruitful contributions at Vaccines-2012.
"Vaccines-2012 proceedings "
All accepted abstracts have been indexed in OMICS International Journal of Vaccines & Vaccination as a special issue. The theme of this Conference was on "Prospects and Development of Prophylactic & Therapeutic Vaccines". Based on this, speaker's discussions included many recommendations.
We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Vaccines-2012, and with their unique feedback, OMICS International would like to announce the "3rd International Conference on Vaccines & Vaccination" to be held at Embassy Suites Las Vegas, USA on the July 29-31, 2013.
The International Conference and Exhibition on Vaccines & Vaccination (Vaccines-2011) was held on November 22-24, 2011 in Philadelphia Airport Marriott Hotel, USA. This successful conference organized by OMICS Group brought together Medical Specialists, Researchers and Vaccine Developers who were delighted with the many speeches, presentations, and discussions, which demonstrated the determination to innovate and improve knowledge on Vaccines.
Vaccines-2011, helped to open new ideas, advanced technologies, innovative approaches towards Vaccines. Several speakers from almost 30 countries have participated in this conference which was carried out through several sessions with the theme "Current Strategies in Vaccination".
Conference highlighted the following topics:
- Vaccines and the basic immune system
- New approaches for B and T cells
- Cellular and molecular-based vaccines
- Vaccines against infectious diseases
- Therapeutic vaccine manufacturing, production and development
- Logical and ethical issues and vaccines
- Experimental and clinical evaluation of therapeutic vaccines
- Basic Vaccinology and modern vaccine discovery technologies
The Luxurious accommodation during the conference also created a relaxed and informal atmosphere with aright setting for highly interactive sessions where the speakers shared the knowledge on current issues and strategies of Vaccines and Vaccination.
We take an immense pleasure in thanking our Keynote Speakers:
- Gary Alan Flory Virginia Department of Environmental Quality, USA
- Gregory J. Tobin Biological Mimetics, Inc. (BMI), USA
- Kei Amemiya US Army Medical Research Institute, USA
- Edmund J. Gosselin Albany Medical College, USA
- Mansour Mohamadzadeh University of Florida, USA and many..
" Vaccines-2011 Proceedings "
We are grateful to all speakers, scientific societies, governmental and non-governmental institutions, Professors, scientists, representatives of patient groups from throughout the world for their commitment and the support. We would like to thank our organizing committee members for providing advice on the agenda, and in supporting the conference. We are grateful to NIH, GSK, Sanofi Pasture, and other sponsors for their invaluable support for the success of the event.
Journal of Vaccines & Vaccination and Journal of Clinical & Cellular Immunology have published all papers presented at this meeting as a special issue.
With the huge optimistic response from Scientific fraternity, Renowned personalities and Editorial board members of OMICS Group across the world, we would like to announce 2nd International Conference on Vaccines and Vaccination August 20-22, 2012 Hilton Chicago/Northbrook, USA. With your overwhelming support for Vaccines-2012 we wish to pioneer a way to an outstanding event.
Our previous attendee’s analysis reveals:
• 90% are involved in or make final purchase decisions
• 60% of our previous conferences visited the Exhibit Floor 3 or more times
• 50% came to keep abreast of new products and technology
• 40% came to find a new supplier, technology or product
Categories Available!!
| Elite sponsor |
| Gold sponsor |
| Silver sponsor |
| Exhibition sponsor |
| Lunch / cocktail sponsor |
| Coffee break sponsor |
| Conference delegate bag sponsor |
| Academic partner |
| Corporate partner |
| Keynote sponsor |
| Outside back cover (color) |
| Inside front cover (color) |
| Inside back cover (color) |
Conference Banner Sponsor
| Elite sponsor |
| Gold sponsor |
| Silver sponsor |
| Exhibition sponsor |
| Lunch / cocktail sponsor |
| Coffee break sponsor |
| Conference delegate bag sponsor |
| Academic partner |
| Corporate partner |
| Keynote sponsor |
| Outside back cover (color) |
| Inside front cover (color) |
| Inside back cover (color) |
| Conference Banner Sponsor |
|
Kenneth Beagley
Istvan Toth
Tarl Prow
Mohammed Alsharifi
